Correlation Between Day One and Sonnet Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Day One and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Day One and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Sonnet Biotherapeutics.
Diversification Opportunities for Day One and Sonnet Biotherapeutics
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Day and Sonnet is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Day One i.e., Day One and Sonnet Biotherapeutics go up and down completely randomly.
Pair Corralation between Day One and Sonnet Biotherapeutics
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.32 times more return on investment than Sonnet Biotherapeutics. However, Day One Biopharmaceuticals is 3.12 times less risky than Sonnet Biotherapeutics. It trades about -0.27 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.29 per unit of risk. If you would invest 1,485 in Day One Biopharmaceuticals on September 14, 2024 and sell it today you would lose (204.00) from holding Day One Biopharmaceuticals or give up 13.74% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. Sonnet Biotherapeutics Holding
Performance |
| Timeline |
| Day One Biopharmaceu |
| Sonnet Biotherapeutics |
Day One and Sonnet Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and Sonnet Biotherapeutics
The main advantage of trading using opposite Day One and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.| Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
| Sonnet Biotherapeutics vs. Puma Biotechnology | Sonnet Biotherapeutics vs. Iovance Biotherapeutics | Sonnet Biotherapeutics vs. Day One Biopharmaceuticals | Sonnet Biotherapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stocks Directory Find actively traded stocks across global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |